Medpace Holdings, Inc. Operating Income Loss

Quick Answer

Medpace Holdings, Inc. reported Operating Income Loss of $534.94 million for the year ending 2025.

  • Medpace Holdings, Inc. showed an increase of +19.7% in Operating Income Loss from 2024 to 2025.
  • This data is from Medpace Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on February 10, 2026.
  • XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 11 years of available data (2015 to 2025), Medpace Holdings, Inc.'s Operating Income Loss has grown by 2,501.6%.
  • Historical annual values: Fiscal year 2025: $534.94 million | Fiscal year 2024: $446.87 million | Fiscal year 2023: $336.83 million | Fiscal year 2022: $278.70 million | Fiscal year 2021: $198.62 million | Fiscal year 2020: $167.04 million | Fiscal year 2019: $127.26 million | Fiscal year 2018: $101.05 million | Fiscal year 2017: $64.86 million | Fiscal year 2016: $52.49 million | Fiscal year 2015: $20.56 million.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: